FosunKairos Overview

  • Status
  • Acquired/​Merged

  • Employees
  • 148

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 5

FosunKairos General Information

Description

Developer of tumour immunotherapy products designed to advance cell and gene therapy for cancer treatment. The company offers CAR-T and TCR-T pipelines, localised manufacturing capabilities, and integrated research and commercialisation expertise, enabling oncology care providers and biopharmaceutical sectors to improve access to advanced cell therapies and enhance treatment outcomes.

Contact Information

Formerly Known As
Fosun Kite, Fosun Kite Bio, Fosun Kite Biotechnology
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Venture Capital-Backed
Corporate Office
  • Number 2277 Kangxin Road, Pudong New Area
  • Shanghai, 201210
  • China
+86 021
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Parent Company
Vertical(s)
Corporate Office
  • Number 2277 Kangxin Road, Pudong New Area
  • Shanghai, 201210
  • China
+86 021

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

FosunKairos Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC 26-May-2026 Completed Generating Revenue
5. Later Stage VC 28-Apr-2026 Completed Generating Revenue
4. Later Stage VC (Series A) 05-Dec-2025 Completed Generating Revenue
3. Merger/Acquisition 13-Sep-2024 Completed Generating Revenue
2. Secondary Transaction - Private 27-Dec-2023 Completed Generating Revenue
1. Joint Venture 01-Apr-2017 Completed Generating Revenue
To view FosunKairos’s complete valuation and funding history, request access »

FosunKairos Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of tumour immunotherapy products designed to advance cell and gene therapy for cancer treatment. The company o
Drug Discovery
Shanghai, China
148 As of 2019

Abingdon, United Kingdom
 

Lexington, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

FosunKairos Competitors (48)

One of FosunKairos’s 48 competitors is Adaptimmune Therapeutics, a Formerly VC-backed company based in Abingdon, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Adaptimmune Therapeutics Formerly VC-backed Abingdon, United Kingdom
Agenus Formerly VC-backed Lexington, MA
Centrose Venture Capital-Backed Madison, WI
Sorrento Therapeutics Formerly VC-backed San Diego, CA
Immunocore Holdings Formerly VC-backed Abingdon, United Kingdom
You’re viewing 5 of 48 competitors. Get the full list »

FosunKairos Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

FosunKairos Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Jameho Investment PE/Buyout Minority
Kite Pharma Corporation Majority
To view FosunKairos’s complete investors history, request access »

FosunKairos FAQs

  • Where is FosunKairos headquartered?

    FosunKairos is headquartered in Shanghai, China.

  • What is the size of FosunKairos?

    FosunKairos has 148 total employees.

  • What industry is FosunKairos in?

    FosunKairos’s primary industry is Drug Discovery.

  • Is FosunKairos a private or public company?

    FosunKairos is a Private company.

  • What is FosunKairos’s current revenue?

    The current revenue for FosunKairos is .

  • How much funding has FosunKairos raised over time?

    FosunKairos has raised $91.6M.

  • Who are FosunKairos’s investors?

    Jameho Investment and Kite Pharma have invested in FosunKairos.

  • Who are FosunKairos’s competitors?

    Adaptimmune Therapeutics, Agenus, Centrose, Sorrento Therapeutics, and Immunocore Holdings are some of the 48 competitors of FosunKairos.

  • When was FosunKairos acquired?

    FosunKairos was acquired on 26-May-2026.

  • Who acquired FosunKairos?

    FosunKairos was acquired by Fosun Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process